A Discussion with Dr Andre Schuh

The Treatment and Management of AML in 2024

Join us on October 7, 2024, from 8:00 pm to 9:00 pm EST to discuss an evidence-based approach for the diagnosis, treatment, and sequencing in the management of AML in 2024.

Welcome to Canadian Hematology Today’s 2024 Webinar Series!

It’s our pleasure to invite you to join us for this presentation and discussion with Dr Andre Schuh from the Princess Margaret Cancer Centre as we explore the treatment and management of AML in 2024.

Meet Dr. Andre Schuh

Dr. Andre Schuh obtained his MD degree at the University of Toronto, Ontario, Canada, in 1983, and thereafter received subspecialty certification in Internal Medicine (1987) and Hematology (1988), followed by a four year Molecular Biology Fellowship. Dr. Schuh has been a staff physician at the University Health Network/Princess Margaret Cancer Centre, Toronto, Ontario, since 1992, where he has long focused on acute leukemia and MDS.

Subscribe To Canadian Hematology Today

Canadian Hematology Today provides a forum for the clinical community to share real-world experience and the latest best practices in the treatment and management of hematologic disease.

The journal is published thrice yearly in English and French and is circulated to over 1,100 hematology clinicians and researchers across Canada. It features peer-reviewed articles that present robust clinical perspectives and practical insights into disease management.

About Catalytic Health

Founded in 2009, Catalytic Health is one of Canada’s largest medical education agencies and reaches over 50,000 Canadian clinicians a year with its educational programs, services and platforms. Catalytic Health is also the largest independent medical publisher in Canada, one of the largest scientific conference providers, and a leader in innovative events and services for the Life Sciences industry. Learn more about Catalytic Health.